{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:14:23Z","timestamp":1767204863971,"version":"build-2238731810"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009988","name":"Huzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate whether the functional OXTR rs2254298 polymorphism moderates escitalopram response in Generalized Anxiety Disorder (GAD) through oxytocin (OT) neuroendocrine signaling, with specific consideration of sex-specific effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>88 patients with GAD and 92 matched healthy controls (HCs) were enrolled. All participants underwent OXTR rs2254298 genotyping and baseline serum OT measurement. GAD patients then received 8 weeks of escitalopram monotherapy. Anxiety severity was assessed using the Hamilton Anxiety Scale (HAMA) at baseline and weeks 2, 4, and 8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline serum OT levels were significantly elevated in GAD patients compared to HCs (126.28 \u00b1 88.41 vs. 92.77 \u00b1 47.51 pg\/mL, p = 0.006), a difference that was primarily driven by female patients (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.037). OT levels were positively correlated with baseline HAMA scores (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.197,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008). After 8 weeks of treatment, the OXTR rs2254298 genotype distribution significantly differed between treatment responders and non-responders (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.049), with GG homozygotes showing a lower response rate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that the OXTR rs2254298 polymorphism may influence escitalopram response in GAD via OT neuroendocrine mechanisms, exhibiting prominent sexual dimorphism. Integrating genetic profiling with endocrine biomarkers holds promise for personalizing anxiety treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1718106","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:29:13Z","timestamp":1763706553000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder: a sex-specific role for oxytocin signaling"],"prefix":"10.3389","volume":"16","author":[{"given":"Liang","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfen","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2025.2529974","article-title":"Generalized anxiety disorder: epidemiology, burden, and comorbid depression","volume":"41","author":"Druet-Cabanac","year":"2025","journal-title":"Curr Med Res Opin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamapsychiatry.2020.2496","article-title":"Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder: A Randomized Clinical Trial","volume":"78","author":"Simon","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/08919887241289533","article-title":"A proposed algorithm for the pharmacological treatment of generalized anxiety disorder in the older patient","volume":"38","author":"Chen","year":"2025","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-024-02626-0","article-title":"Effective targets of intervention on generalized anxiety symptoms across whole adolescence and emerging adulthood: network analysis and insilico intervention","volume":"34","author":"Li","year":"2025","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-32-9705-0_7","article-title":"The role of the oxytocin system in anxiety disorders","volume":"1191","author":"Yoon","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.30773\/pi.2018.08.31","article-title":"The relationship between plasma oxytocin levels and social anxiety symptoms","volume":"15","author":"Oh","year":"2018","journal-title":"Psychiatry Investig"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2008.00051.x","article-title":"Oxytocin levels in social anxiety disorder","volume":"14","author":"Hoge","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"103903","DOI":"10.1016\/j.archger.2019.103903","article-title":"Association of oxytocin levels and oxytocin receptor gene polymorphism (rs2254298) with cardiovascular risk factors in Brazilian elderly from Primary Health Care","volume":"84","author":"Jacondino","year":"2019","journal-title":"Arch Gerontol Geriatr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000508074","article-title":"Polymorphism of the oxytocin receptor (OXTR) gene affects the circulating oxytocin receptor levels in late-term pregnancy in a turkish population[J","volume":"85","author":"Akdemir","year":"2020","journal-title":"Gynecol Obstet Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2010.07.003","article-title":"Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls","volume":"36","author":"Thompson","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0308728","DOI":"10.1371\/journal.pone.0308728","article-title":"Epistatic interactions between oxytocin- and dopamine-related genes and trust","volume":"19","author":"Koyama","year":"2024","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/200392","article-title":"Current perspectives on the role of oxytocin receptor (OXTR) gene variants in panic disorder: associations with disease liability and separation anxiety","author":"Yegin","year":"2025","journal-title":"Arch Med Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1085429","article-title":"The oxytocin receptor rs2254298 polymorphism and alcohol withdrawal symptoms: a gene-environment interaction in mood disorders","volume":"14","author":"Shen","year":"2023","journal-title":"Front Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10578-022-01419-3","article-title":"Genetic variations in elements of the oxytocinergic pathway are associated with attention\/hyperactivity problems and anxiety problems in childhood","volume":"55","author":"Camerini","year":"2024","journal-title":"Child Psychiatry Hum Dev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1380779","article-title":"Sex differences in the effects of aromatherapy on anxiety and salivary oxytocin levels","volume":"15","author":"Nakajima","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1017\/SJP.2021.46","article-title":"Mediation, moderation, and conditional process analysis: concepts, computations, and some common confusions","volume":"24","author":"Igartua","year":"2021","journal-title":"Span J Psychol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10578-022-01434-4","article-title":"Joint roles of oxytocin- and dopamine-related genes and childhood parenting experience in maternal supportive social network","volume":"55","author":"Koyama","year":"2024","journal-title":"Child Psychiatry Hum Dev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13668","DOI":"10.1111\/jsr.13668","article-title":"Genotype-genotype interactions of the OXTR gene polymorphisms are associated with self-reported daytime dysfunction, sleep latency and personal distress","volume":"32","author":"Li","year":"2023","journal-title":"J Sleep Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2024.111909","article-title":"The impact of genetic variations in the serotonergic system on symptom severity and clinical outcome in functional neurological disorders","volume":"186","author":"Weber","year":"2024","journal-title":"J Psychosom Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cdev.12493","article-title":"Oxytocin receptor genetic and epigenetic variations: association with child abuse and adult psychiatric symptoms","volume":"87","author":"Smearman","year":"2016","journal-title":"Child Dev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1017\/S003329172300274X","article-title":"The impact of childhood trauma exposure on social functioning in schizophrenia: the moderated mediation role of oxytocin and oxytocin receptor gene polymorphisms","volume":"54","author":"Goh","year":"2024","journal-title":"Psychol Med"}],"updated-by":[{"DOI":"10.3389\/fpsyt.2025.1754488","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000}}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1718106\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:26:52Z","timestamp":1765358812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1718106\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":21,"alternative-id":["10.3389\/fpsyt.2025.1718106"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1718106","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"article-number":"1718106"}}